{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:00:34Z","timestamp":1788091234705,"version":"build-2803163510"},"publisher-location":"Boston, MA","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781461372035","type":"print"},{"value":"9781461548577","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4857-7_54","type":"book-chapter","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:44:47Z","timestamp":1318952687000},"page":"349-357","source":"Crossref","is-referenced-by-count":25,"title":["The Effect of Methylprednisolone Pulse Therapy in Polymyositis\/Dermatomyositis"],"prefix":"10.1007","author":[{"given":"H. D.","family":"Bolosiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rednic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"54_CR1","volume-title":"Management of inflammatory muscle disease","author":"LJ Kagen","year":"1995","unstructured":"Kagen L.J.: Management of inflammatory muscle disease, in John H. Klippel, Paul A. Dieppe, (Eds): textbook of Rheumatology, Mosby, 1995."},{"issue":"6","key":"54_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00002281-199611000-00008","volume":"8","author":"L Vilalba","year":"1996","unstructured":"Vilalba L., Adams E.M.: Update on therapy for refractory dermatomyositis and polymyositis.[Review]. Curr. Opin. Rheumatol. 8(6):544\u201351 (1996).","journal-title":"Curr. Opin. Rheumatol"},{"key":"54_CR3","first-page":"643","volume":"21","author":"RG Fafalak","year":"1994","unstructured":"Fafalak R.G., Peterson M.C.E., Kagen L.J.: Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J.Rheumatol. 21:643\u201348 (1994).","journal-title":"J.Rheumatol"},{"key":"54_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2008-1041071","volume":"14","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC: How to diagnose and treat the inflammatory myopathies. Sem. Neurol. 14:137\u2013145 (1994).","journal-title":"Sem. Neurol"},{"key":"54_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00019052-199606000-00015","volume":"9","author":"MC Dalakas","year":"1994","unstructured":"Dalakas M.C., Sivakumar K: The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr. Opin. Neurol. 9:235\u2013239 (1994).","journal-title":"Curr. Opin. Neurol"},{"key":"54_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","volume":"59","author":"DS Tews","year":"1995","unstructured":"Tews DS, Goebel H.H: Expression of cell adhesion molecules in inflammatory myopathies. J. Neuroimunol. 59:185\u2013194 (1995).","journal-title":"J. Neuroimunol"},{"key":"54_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00019052-199606000-00014","volume":"9","author":"JR Mendell","year":"1996","unstructured":"Mendell J.R., Trishwant S.G., Kissel J.T.: The immunopathogenic role of complement in human muscle disease. Curr.Opin. Neurol. 9:226\u2013234 (1996).","journal-title":"Curr.Opin. Neurol"},{"key":"54_CR8","volume-title":"Glucocorticoids","author":"LG Axelrod","year":"1993","unstructured":"Axelrod LG.: Glucocorticoids, in Kelley, Harris, Rudley, Sledge (Eds): Textbook of Rheumatology, New York, 1993."},{"issue":"2","key":"54_CR9","first-page":"57","volume":"25","author":"R Numo","year":"1996","unstructured":"Numo, R.: Inflammatory muscle disease: prognosis and therapy. Rheumatol. Europe 25(2): 57\u201359 (1996).","journal-title":"Rheumatol. Europe"},{"issue":"1\u20132","key":"54_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0165-5728(97)00033-7","volume":"76","author":"S Matsubara","year":"1997","unstructured":"Matsubara S., Hirai S., Sawa Y: Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle. J. Neuroimmunol. 76(1\u20132): 75\u201380 (1997).","journal-title":"J. Neuroimmunol"},{"key":"54_CR11","volume-title":"Clinical features of inflammatory muscle disease","author":"TA Medsger","year":"1995","unstructured":"Medsger T.A., Oddis C.V.: Clinical features of inflammatory muscle disease, in John H. Klippel, Paul A. Dieppe (Eds): Textbook of Rheumatology, Mosby, 1995."},{"issue":"3","key":"54_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/rheumatology\/33.3.231","volume":"33","author":"R Sanmarti","year":"1994","unstructured":"Sanmarti R., Collado A, Gratacos J. et al.: Reduced activity of serum creatine kinase in rheumatoid arthritis: a phenomenon linked to the inflammatory response. Br.J. Rheumatol. 33(3):231\u20134 (1994).","journal-title":"Br.J. Rheumatol"}],"container-title":["Advances in Experimental Medicine and Biology","Rheumaderm"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4857-7_54.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T11:37:00Z","timestamp":1619869020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4857-7_54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461372035","9781461548577"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4857-7_54","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1999]]}}}